solifenacin succinate 5 MG Oral Tablet

1 INDICATIONS AND USAGE Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. (1)

Amneal Pharmaceuticals NY LLC

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] nausea` `[4] diarrhoea` `[5] off label use` `[6] dyspnoea` `[7] headache` `[8] pain` `[9] vomiting` `[10] chronic kidney disease`

4 years ago

ROUND YELLOW AC 07

16 HOW SUPPLIED/STORAGE AND HANDLING

SOLIFENACIN SUCCINATE Tablets, 5 mg are light yellow, round shaped film-coated tablet debossed with “AC” and “07” on one side and plain on other side. They are supplied as follows: Bottles of 30: NDC 69238-1308-3 Bottles of 90: NDC 69238-1308-9 Cartons of 30 (3 x 10 Unit-Dose Tablets): NDC 69238-1308-7

SOLIFENACIN SUCCINATE Tablets, 10 mg are light pink, round shaped film-coated tablet debossed with “AC” and “09” on one side and plain on other side. They are supplied as follows: Bottles of 30: NDC 69238-1309-3 Bottles of 90: NDC 69238-1309-9 Cartons of 30 (3 x 10 Unit-Dose Tablets): NDC 69238-1309-7 Store at 20° to 25ºC (68° to 77ºF); excursions permitted between 15º to 30ºC (59° to 86ºF) [see USP Controlled Room Temperature]. Dispense in a tight container as defined in the USP.

More pills like ROUND AC 07

Related Pills

solifenacin succinate 10 MG Oral Tablet

Amneal Pharmaceuticals NY LLC

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site